AdaptHealth/$AHCO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About AdaptHealth

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Ticker

$AHCO
Primary listing

Industry

Health Care Providers & Services

Employees

10,500

ISIN

US00653Q1022

AdaptHealth Metrics

BasicAdvanced
$1.1B
14.67
$0.58
1.64
-

What the Analysts think about AdaptHealth

Analyst ratings (Buy, Hold, Sell) for AdaptHealth stock.

Bulls say / Bears say

AdaptHealth's recent refinancing of its senior secured credit facility has extended maturity to September 2029 and reduced the cost of debt, potentially improving financial stability and profitability. (stocktitan.net)
Analysts from Canaccord Genuity Group and Truist Financial have raised their price targets for AdaptHealth to $14.00, maintaining a 'buy' rating, indicating confidence in the company's growth prospects. (techdows.com)
AdaptHealth reported a 6.3% year-over-year increase in net revenue for Q3 2024, driven by strong performance in sleep products, suggesting robust demand in key segments. (benzinga.com)
AdaptHealth's Q3 2024 net income fell short of analyst expectations, leading to a stock price decline of approximately 9.56%. (gurufocus.com)
The company adjusted its full-year revenue guidance downward to a range of $3.22 billion to $3.26 billion, below previous estimates, indicating potential challenges in meeting growth targets. (gurufocus.com)
Insider selling activity, including the COO selling 25,000 shares, may signal concerns about the company's future performance among top executives. (techdows.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.

AdaptHealth Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

AdaptHealth Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AHCO

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs